Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

117.50p
   
  • Change Today:
    -1.00p
  • 52 Week High: 134.00
  • 52 Week Low: 84.50
  • Currency: UK Pounds
  • Shares Issued: 84.68m
  • Volume: 5,293
  • Market Cap: £99.50m
  • RiskGrade: 196
  • Beta: 0.15

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
53.55% above the market average53.55% above the market average53.55% above the market average53.55% above the market average53.55% above the market average
72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
20.12% above the market average20.12% above the market average20.12% above the market average20.12% above the market average20.12% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average
Price Book Ratio
54.59% below the market average54.59% below the market average54.59% below the market average54.59% below the market average54.59% below the market average
17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
59.18% below the market average59.18% below the market average59.18% below the market average59.18% below the market average59.18% below the market average
29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average
Price Chg 3m
28.96% below the market average28.96% below the market average28.96% below the market average28.96% below the market average28.96% below the market average
18.92% above the sector average18.92% above the sector average18.92% above the sector average18.92% above the sector average18.92% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
62.73% below the market average62.73% below the market average62.73% below the market average62.73% below the market average62.73% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Momentum 20
60.36% below the market average60.36% below the market average60.36% below the market average60.36% below the market average60.36% below the market average
88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
50.49% below the market average50.49% below the market average50.49% below the market average50.49% below the market average50.49% below the market average
8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
64.19% below the market average64.19% below the market average64.19% below the market average64.19% below the market average64.19% below the market average
31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
17.11% below the market average17.11% below the market average17.11% below the market average17.11% below the market average17.11% below the market average
25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average25.71% above the sector average
Operating Profit Loss
61.52% below the market average61.52% below the market average61.52% below the market average61.52% below the market average61.52% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
2.30% above the market average2.30% above the market average2.30% above the market average2.30% above the market average2.30% above the market average
31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average31.43% above the sector average
Cash
24.94% above the market average24.94% above the market average24.94% above the market average24.94% above the market average24.94% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
52.00% above the market average52.00% above the market average52.00% above the market average52.00% above the market average52.00% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Buys 1y
0.22% below the market average0.22% below the market average0.22% below the market average0.22% below the market average0.22% below the market average
6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 117.50p
Change Today -1.00p
% Change -0.84 %
52 Week High 134.00
52 Week Low 84.50
Volume 5,293
Shares Issued 84.68m
Market Cap £99.50m
Beta 0.15
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.49% below the market average34.49% below the market average34.49% below the market average34.49% below the market average34.49% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Price Trend
63.37% above the market average63.37% above the market average63.37% above the market average63.37% above the market average63.37% above the market average
83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average
Income Not Available
Growth
19.30% above the market average19.30% above the market average19.30% above the market average19.30% above the market average19.30% above the market average
27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average

Diaceutics Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
14:26 5,000 @ 117.10p
13:19 268 @ 118.15p
11:20 2 @ 120.00p
11:20 7 @ 117.00p
11:20 16 @ 117.00p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page